Revenue | ₹57.35Cr |
Net Profits | ₹-13.80Cr |
Net Profit Margins | -24.06% |
Mangalam Drugs and Organics Ltd’s revenue fell -25.09% since last year same period to ₹57.35Cr in the Q1 2025-2026. On a quarterly growth basis, Mangalam Drugs and Organics Ltd has generated -21.71% fall in its revenue since last 3-months.
Mangalam Drugs and Organics Ltd’s net profit fell -614.93% since last year same period to ₹-13.80Cr in the Q1 2025-2026. On a quarterly growth basis, Mangalam Drugs and Organics Ltd has generated -23100% fall in its net profits since last 3-months.
Mangalam Drugs and Organics Ltd’s net profit margin fell -787.41% since last year same period to -24.06% in the Q1 2025-2026. On a quarterly growth basis, Mangalam Drugs and Organics Ltd has generated -29476.63% fall in its net profit margins since last 3-months.
The revenue for Mangalam Drugs and Organics Ltd in the Q1 results 2025 was ₹57.35Cr.
The net profit for Mangalam Drugs and Organics Ltd in the Q1 results 2025 was ₹-13.80Cr.
The net profit margin for Mangalam Drugs and Organics Ltd in the Q1 results 2025 was -24.06%.
The revenue for Mangalam Drugs and Organics Ltd in the Q1 results 2024 was ₹76.56Cr.
The net profit for Mangalam Drugs and Organics Ltd in the Q1 results 2024 was ₹2.68Cr.
The net profit margin for Mangalam Drugs and Organics Ltd in the Q1 results 2024 was 3.50%.